TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS Branded Medicines Tranche Framework for London and South of England

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published3
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS Branded Medicines Tranche Framework for London and South of England". Published status: complete. Published value: Value not published. 3 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
49.6Bids / Report
38.2% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 752 active published awards; 747 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published20 Aug 2024, 14:23 BST
Last source update20 Aug 2024, 14:23 BST
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-0445bc
What is being bought
NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024<br/>Offer reference number: CM/PHR/22/5689<br/>CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South of England Tranche A. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.<br/>CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South of England Tranche B. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.<br/>CM/PHR/22/5689/03 - NHS Framework for the supply of Omalizumab and Diroximel Fumarate for the Midlands & East and North of England. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
What changed
From the official release history
  1. tender value changed
    20 Aug 2024, 14:23 BST
  2. Status changed to complete
    20 Aug 2024, 14:23 BST
  3. Official notice release published
    20 Aug 2024, 14:23 BST
  4. Submission deadline changed to published date
    20 Aug 2024, 14:23 BST
  5. Buyer information updated
    20 Aug 2024, 14:23 BST
  6. Published value updated to £832,292,000
    5 Mar 2024, 15:51 GMT
  7. Status changed to active
    5 Mar 2024, 15:51 GMT
  8. Official notice release published
    5 Mar 2024, 15:51 GMT
  9. Submission deadline changed to 5 Apr 2024, 13:00 BST
    5 Mar 2024, 15:51 GMT
  10. Buyer information updated
    5 Mar 2024, 15:51 GMT
Lots and requirements (3)
Published by the contracting authority
  • Lot 1 · #1
    CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1
    cancelled
    Published valueNot published
    CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South of England Tranche A. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2
    cancelled
    Published valueNot published
    CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South of England Tranche B. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #3
    CM/PHR/22/5689/03 - Omalizumab and Diroximel Fumarate for MAE & NOFE - Lot 3
    cancelled
    Published valueNot published
    CM/PHR/22/5689/03 - NHS Framework for the supply of Omalizumab and Diroximel Fumarate for the Midlands & East and North of England. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    20 Aug 2024, 14:23 BST
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Award active
    Not published · Not published
  13. Award active
    Not published · Not published
  14. Award active
    Not published · Not published
  15. Award active
    Not published · Not published
  16. Award active
    Not published · Not published
  17. Award active
    Not published · Not published
  18. Award active
    Not published · Not published
  19. Award active
    Not published · Not published
  20. Award active
    Not published · Not published
  21. Award active
    Not published · Not published
  22. Award active
    Not published · Not published
  23. Award active
    Not published · Not published
  24. Award active
    Not published · Not published
  25. Award active
    Not published · Not published
  26. Award active
    Not published · Not published
  27. Award active
    Not published · Not published
  28. Award active
    Not published · Not published
  29. Award active
    Not published · Not published
  30. Award active
    Not published · Not published
  31. Award active
    Not published · Not published
  32. Award active
    Not published · Not published
  33. Award active
    Not published · Not published
  34. Award active
    Not published · Not published
  35. Award active
    Not published · Not published
  36. Award active
    Not published · Not published
  37. Award active
    Not published · Not published
  38. Award active
    Not published · Not published
  39. Award active
    Not published · Not published
  40. Award active
    Not published · Not published
  41. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  42. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  43. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  44. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  45. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  46. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  47. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  48. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  49. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  50. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  51. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  52. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  53. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  54. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  55. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  56. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  57. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  58. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  59. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  60. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  61. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  62. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  63. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  64. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  65. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  66. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  67. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  68. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  69. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  70. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  71. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  72. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  73. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  74. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  75. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  76. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  77. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  78. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
  79. Contract active
    Signed 22 Jul 2024, 00:00 BST · £1
Commercial outcome and competition
Awards
Sun Pharma UK Ltd
Not published · Not published · active
ACCORD-UK LTD
Not published · Not published · active
Manx Healthcare Ltd
Not published · Not published · active
Chugai Pharma UK Ltd
Not published · Not published · active
Napp Pharmaceuticals Ltd
Not published · Not published · active
Dr.Reddy's Laboratories (UK) Limited
Not published · Not published · active
Gedeon Richter UK Ltd
Not published · Not published · active
Teva UK Limited
Not published · Not published · active
Merck Sharpe and Dohme (UK) Limited
Not published · Not published · active
Celltrion Healthcare United Kingdom Limited
Not published · Not published · active
Janssen-Cilag Ltd
Not published · Not published · active
Biogen
Not published · Not published · active
Organon Pharmaceuticals UK Ltd
Not published · Not published · active
Thornton and Ross Ltd
Not published · Not published · active
GlaxoSmithKline UK Limited
Not published · Not published · active
Takeda UK Ltd
Not published · Not published · active
Pfizer Ltd
Not published · Not published · active
Zentiva Pharma UK Ltd
Not published · Not published · active
Roche Products Ltd
Not published · Not published · active
Eli Lilly and Company Ltd
Not published · Not published · active
Aventis Pharma ltd t/a Sanofi
Not published · Not published · active
ACCORD-UK LTD
Not published · Not published · active
Celltrion Healthcare United Kingdom Limited
Not published · Not published · active
Orifarm UK
Not published · Not published · active
Galapagos Biotech Ltd
Not published · Not published · active
Dr.Reddy's Laboratories (UK) Limited
Not published · Not published · active
LEO Pharma
Not published · Not published · active
BIOSIMILAR COLLABORATIONS IRELAND LIMITED
Not published · Not published · active
Sobi (Swedish Orphan Biovitrum Ltd)
Not published · Not published · active
UCB Pharma Ltd (primary)
Not published · Not published · active
Biogen
Not published · Not published · active
Celltrion Healthcare United Kingdom Limited
Not published · Not published · active
NOVARTIS PHARMACEUTICALS UK LIMITED
Not published · Not published · active
AstraZeneca
Not published · Not published · active
Thornton and Ross Ltd
Not published · Not published · active
GlaxoSmithKline UK Limited
Not published · Not published · active
Novartis Pharmaceuticals UK Ltd
Not published · Not published · active
Eli Lilly and Company Ltd
Not published · Not published · active
Aventis Pharma t/a Sanofi
Not published · Not published · active
Contracts
NHS Framework for Branded Medicines - London & South of England
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 2
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 3
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 3
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England - Lot 3
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England
£1 · signed 22 Jul 2024, 00:00 BST · active
NHS Framework for Branded Medicines - London & South of England
£1 · signed 22 Jul 2024, 00:00 BST · active
Bid statistics
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromNonEU: 16 (lot 1)
foreignBidsFromNonEU: 16 (lot 1)
Buyer and organisations in this procedure

NHS England

Contracting authority GB-FTS-118033
View buyer profile

  • NHS England
    buyer
    centralPurchasingBody

    7&8 Wellington Place, Leeds, UKE, LS1 4AP
    lynne.tierney@nhs.net

  • ACCORD-UK LTD
    supplier

    00079585
    Whiddon Valley Barnstaple Devon EX32 8NS, Barnstaple, UK, EX32 8NS

  • ACCORD-UK LTD
    supplier

    00079585
    Whiddon Valley, Barnstaple, Devon, Barnstaple, UK, EX32 8NS

  • AstraZeneca
    supplier

    London, UK, N1C 4AG

  • Aventis Pharma ltd t/a Sanofi
    supplier

    Reading, UK, RG6 1PT

  • Aventis Pharma t/a Sanofi
    supplier

    01535640
    410 Thames Valley Park Drive, Reading, UK, RG6 1PT
    +49 0800854430

  • BIOSIMILAR COLLABORATIONS IRELAND LIMITED
    supplier

    London, UK, WC2B 5AH

  • Biogen
    supplier

    Maidenhead, Maidenhead, UK, SL6 3UD

  • Biogen
    supplier

    Maidenhead, UK, SL6 3UD

  • Celltrion Healthcare United Kingdom Limited
    supplier

    11685363
    The Switch, 1-7 The Grove, Slough, Slough, UK, SL1 1QP

  • Celltrion Healthcare United Kingdom Limited
    supplier

    Slough, UK, SL1 1QP

  • Chugai Pharma UK Ltd
    supplier

    02814621
    2nd Floor, Mulliner House. Flanders Road, Turnham Green, London., London, UK, W4 1NN
    +49 07887537432

  • Dr.Reddy's Laboratories (UK) Limited
    supplier

    Cambridge, UK, CB4 0PE

  • Eli Lilly and Company Ltd
    supplier

    Basingstoke, UK, RG21 4FA

  • Galapagos Biotech Ltd
    supplier

    Uxbridge, UK, UB8 1QS

  • Gedeon Richter UK Ltd
    supplier

    London, UK, W9 2EP

  • GlaxoSmithKline UK Limited
    supplier

    Brentford, UK, TW8 9GS

  • Janssen-Cilag Ltd
    supplier

    High Wycombe, UK, HP12 4EG

  • LEO Pharma
    supplier

    Maidenhead, UK, SL6 3UD

  • Manx Healthcare Ltd
    supplier

    Warwick, UK, CV34 6UQ

  • Merck Sharpe and Dohme (UK) Limited
    supplier

    London, UK, EC2M 6UR

  • NOVARTIS PHARMACEUTICALS UK LIMITED
    supplier

    00119006
    2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, London, UK, W12 7FQ

  • Napp Pharmaceuticals Ltd
    supplier

    Cambridge, UK, CB4 0AB

  • Novartis Pharmaceuticals UK Ltd
    supplier

    London, UK, W12 7FQ

  • Organon Pharmaceuticals UK Ltd
    supplier

    London, UK, EC2A 3NP

  • Orifarm UK
    supplier

    Brentwood, UK, CM13 3FR

  • Pfizer Ltd
    supplier

    Tadworth, UK, KT20 7NS

  • Roche Products Ltd
    supplier

    Welwyn Garden City, UK, AL7 1TW

  • Sobi (Swedish Orphan Biovitrum Ltd)
    supplier

    Abington, UK, CB21 6AD

  • Sun Pharma UK Ltd
    supplier

    Uxbridge, UK, UB11 1FW

  • Takeda UK Ltd
    supplier

    London, UK, W2 6BD

  • Teva UK Limited
    supplier

    Castleford, UK, WF10 5HX

  • The High Court
    reviewBody

    The Strand, London, WC2A 2LL

  • Thornton and Ross Ltd
    supplier

    Huddersfield, UK, HD7 5JN

  • Thornton and Ross Ltd
    supplier

    Slaithwaite, UK, HD7 5JN

  • UCB Pharma Ltd (primary)
    supplier

    Slough, UK, SL1 3WE

  • Zentiva Pharma UK Ltd
    supplier

    Guildford, UK, GU1 4QB
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published